Results 231 to 240 of about 192,395 (356)
Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong +5 more
wiley +1 more source
Analyzation of Metabolic Reprogramming in Drug-Resistant MCF-7 Cells
Derick Han, Ho Ching Leung, Andrew Vo
openalex +1 more source
Targeting receptor for activated C kinase 1 with a small molecule induces mitotic catastrophe and suppresses lipid metabolic reprogramming in hepatocellular carcinoma [PDF]
Longyan Wang +11 more
openalex +1 more source
Antibody–drug conjugates (ADCs) transform breast cancer therapy, yet resistance limits their durability. Emerging evidence reveals that ADC failure is not solely tumor‐intrinsic but shaped by dynamic tumor–microenvironment interactions that alter drug delivery, processing, and response.
Minji Seo, Jangsoon Lee, Naoto T. Ueno
wiley +1 more source
Cardiac radiotherapy-induced epigenetic memory underlies electrophysiologic and metabolic reprogramming. [PDF]
Jordan SD +22 more
europepmc +1 more source
This study established an RT‐MSCs‐based therapeutic approach for scleroderma in mice. RT‐MSCs attenuated fibrosis by regulating mitochondrial autophagy and restored gut microbiota homeostasis. Metabolomic analyses confirmed recovery of key metabolites, and RT‐MSCs demonstrated favorable lesion targeting and safety profiles.
Xue Xia +5 more
wiley +1 more source
Metabolic reprogramming in cancer: signaling pathways and therapeutic targets. [PDF]
Dong S, Li T.
europepmc +1 more source

